Heart failure drug shows promise in non-diabetic patients
NCT ID NCT07112274
First seen Jan 03, 2026 · Last updated May 19, 2026 · Updated 24 times
Summary
This study looked at whether empagliflozin, a diabetes drug, can improve heart structure in people with heart failure who have normal pumping ability but are not diabetic. Fifty patients took part. Researchers measured heart stress markers like NT-ProBNP and sST2 to see if the drug helps the heart work better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Rehab Hussein Werida
Damanhūr, Elbehairah, 31527, Egypt
Conditions
Explore the condition pages connected to this study.